- Home
- PSEC vs OLMA Comparison
PSEC vs OLMA Comparison
Compare PSEC & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PSEC | OLMA |
|---|---|---|
| Founded | 2004 | 2006 |
| Country | United States | United States |
| Employees | 8 | N/A |
| Industry | Finance/Investors Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | PSEC | OLMA |
|---|---|---|
| Price | $2.77 | $16.70 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 10 |
| Target Price | $2.50 | ★ $44.89 |
| AVG Volume (30 Days) | ★ 4.2M | 924.0K |
| Earning Date | 05-07-2026 | 05-12-2026 |
| Dividend Yield | ★ 19.22% | N/A |
| EPS Growth | N/A | ★ 15.00 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.45 | $3.89 |
| 52 Week High | $3.77 | $36.26 |
Technical Indicators
Market Signals| Indicator | PSEC | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 59.75 | 50.09 |
| Support Level | $2.72 | $13.11 |
| Resistance Level | $2.82 | $16.99 |
| Average True Range (ATR) | 0.07 | 0.81 |
| MACD | 0.03 | 0.46 |
| Stochastic Oscillator | 63.53 | 75.10 |
Price Performance
Historical ComparisonAbout PSEC Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests mainly in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.